Michael J. LaBarre - Dec 13, 2022 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
SVP, CHIEF TECHNICAL OFFICER
Signature
/s/ James R. Oehler, Attorney-in-Fact
Stock symbol
HALO
Transactions as of
Dec 13, 2022
Transactions value $
-$586,675
Form type
4
Date filed
12/13/2022, 05:09 PM
Previous filing
Nov 16, 2022
Next filing
Jan 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Sale -$290K -4.94K -3.03% $58.67 158K Dec 13, 2022 Direct F1, F2
transaction HALO Common Stock Sale -$297K -5.07K -3.2% $58.66 153K Dec 13, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This disposition was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person
F2 Represents a weighted average sales price per share. These shares were sold at prices ranging from $58.233 to $59.12. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.